Table 5.
Coupled XYZ–FSN Matrix Analysis of Drugs in at Study Area the Year 2016–2018 EFY
| Matrix Classification | Number and % of Items in Closing Stock | % Closing Stock Value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2016 | 2017 | 2018 | ||||
| No. | % | No. | % | No. | % | % | % | % | |
| XF | 65 | 15.5 | 24 | 8.7 | 25 | 7.1 | 56.8 | 44.7 | 32.3 |
| XS | 30 | 7.2 | 16 | 5.8 | 16 | 4.5 | 20.9 | 17.2 | 10.4 |
| XN | 5 | 1.2 | 16 | 5.8 | 23 | 6.5 | 2.5 | 16.2 | 41.3 |
| YF | 47 | 11.2 | 18 | 6.6 | 69 | 19.6 | 6.7 | 5.4 | 1.9 |
| YS | 54 | 12.9 | 12 | 4.4 | 28 | 8 | 7.4 | 2.9 | 4.9 |
| YN | 10 | 2.4 | 11 | 4 | 30 | 8.5 | 1.2 | 2.9 | 5.2 |
| ZF | 45 | 10.7 | 33 | 12 | 3 | 0.9 | 1.1 | 1.9 | 0.2 |
| ZS | 102 | 24.3 | 74 | 26.9 | 36 | 10.2 | 2.5 | 5.8 | 1.3 |
| ZN | 61 | 14.6 | 71 | 25.8 | 122 | 34.7 | 0.9 | 3 | 2.6 |
| Total | 419 | 100 | 275 | 100 | 352 | 100 | 100 | 100 | 100 |
| Category I | 192 | 45.8 | 107 | 38.9 | 136 | 38.6 | 88 | 85.4 | 86.1 |
| Category II | 166 | 39.6 | 97 | 35.3 | 94 | 26.7 | 11.1 | 11.6 | 11.3 |
| Category III | 61 | 14.6 | 71 | 25.8 | 122 | 34.7 | 0.9 | 3 | 2.6 |